| Weight Management |
1 |
1 |
| Obesity |
0 |
1 |
| Bariatric Surgery |
0 |
0.95 |
| Weight Loss |
0 |
0.75 |
| Endoscopy |
0 |
0.39 |
| Biliary Disease |
0 |
0.27 |
| Surgery |
0 |
0.27 |
| Gastroesophageal Reflux Disease |
0 |
0.25 |
| Fellowship |
0 |
0.24 |
| Revenue and Practice Management |
0 |
0.19 |
| Exercise |
0 |
0.18 |
| Nutrition |
0 |
0.18 |
| Body Mass Index |
0 |
0.15 |
| New York |
0 |
0.15 |
| Metabolic Syndrome |
0 |
0.14 |
| Clinical Guidelines |
0 |
0.12 |
| Diet |
0 |
0.12 |
| Hospital |
0 |
0.12 |
| Patient Safety |
0 |
0.11 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.1 |
| Metabolism |
0 |
0.09 |
| Adherence |
0 |
0.06 |
| Adverse Effects |
0 |
0.06 |
| Financial Reimbursement |
0 |
0.06 |
| Hand |
0 |
0.06 |
| Insurance |
0 |
0.06 |
| Lifestyle Counseling |
0 |
0.06 |
| Wound Management |
0 |
0.06 |
| Fatty Liver |
0 |
0.04 |
| Liver Disease |
0 |
0.04 |
| Board Certification |
0 |
0.03 |
| Care Management |
0 |
0.03 |
| Endoscopic Suturing |
0 |
0.03 |
| Gastrointestinal Cancer |
0 |
0.03 |
| Grant |
0 |
0.03 |
| Health Maintenance Organization |
0 |
0.03 |
| Healthcare and Medical Technology |
0 |
0.03 |
| Injectable Medications |
0 |
0.03 |
| Liver |
0 |
0.03 |
| Medical Innovations |
0 |
0.03 |
| Medical Life |
0 |
0.03 |
| Meta-Analysis |
0 |
0.03 |
| Professional Societies |
0 |
0.03 |
| Shared Decision-Making |
0 |
0.03 |
| Suture |
0 |
0.03 |
| Tissue |
0 |
0.03 |
| Tolerance |
0 |
0.03 |
| Transplantation |
0 |
0.03 |